日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Methionine-driven YTHDF1 expression facilitates bladder cancer progression by attenuating RIG-I-modulated immune responses and enhancing the eIF5B-PD-L1 axis

甲硫氨酸驱动的YTHDF1表达通过减弱RIG-I调节的免疫反应和增强eIF5B-PD-L1轴促进膀胱癌进展。

期刊:Cell Death and Differentiation
影响因子:15.4
doi:10.1038/s41418-024-01434-y
Yu, Anze; Fu, Liangmin; Jing, Lanyu; Wang, Yinghan; Ma, Zifang; Zhou, Xinwei; Yang, Rui; Liu, Jinhui; Hu, Jiao; Feng, Wei; Yang, Taowei; Chen, Zhenhua; Zu, Xiongbing; Chen, Wei; Chen, Junxing; Luo, Junhang
肿瘤
肿瘤免疫
IF5
PD-L1
膀胱癌
免疫/内分泌
发表日期：2025
文献求助 收藏

STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis

STX17-DT通过抑制线粒体活性氧（ROS）积累和铁死亡，促进肾细胞癌对阿昔替尼产生耐药性。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07456-9
Pan, Yihui; Liu, Shuang; Shu, Guannan; Chen, Minyu; Fu, Liangmin; Chen, Cheng; Chen, Yimeng; Zhuang, Qianfeng; Xue, Dong; He, Xiaozhou
肿瘤
肿瘤免疫
肾癌
铁死亡
线粒体
细胞生物学
发表日期：2025
文献求助 收藏

Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.

肿瘤突变负荷与肿瘤微环境之间的相互作用可预测泛癌抗PD-1/PD-L1疗法的预后

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1557461
Liao Wuyuan, Zhou Xinwei, Lin Hansen, Feng Zihao, Chen Xinyan, Chen Yuhang, Chen Minyu, Lin Mingjie, Yao Gaosheng, Chen Jinwei, Feng Haoqian, Wang Yinghan, Tan Zhiping, Tan Youyan, Lu Jun, Li Pengju, Wei Jinhuan, Luo Li, Fu Liangmin
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis

更正：无标记液相色谱-串联质谱蛋白质组学分析揭示 CLIC1 可作为膀胱癌分期和预后的预测性生物标志物

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1216134
Wang, Weifeng; Huang, Guankai; Lin, Hansen; Ren, Lei; Fu, Liangmin; Mao, Xiaopeng
肿瘤
肿瘤免疫
膀胱癌
发表日期：2023
文献求助 收藏

Development and validation of a novel defined mutation classifier based on Lasso logistic regression for predicting the overall survival of immune checkpoint inhibitor therapy in renal cell carcinoma

基于 Lasso 逻辑回归的新型突变分类器开发与验证，用于预测肾细胞癌免疫检查点抑制剂治疗的总体生存期

期刊:Translational Andrology and Urology
影响因子:1.7
doi:10.21037/tau-23-21
Chen, Minyu; Li, Pengju; Yao, Haohua; Liu, Fei; Fu, Liangmin; Wang, Yinghan; Zhu, Jiangquan; Xu, Quanhui; Liang, Hui; Zhou, Yayun; Wang, Zhu; Deng, Qiong; Chen, Wei; Cao, Jiazheng; Chen, Xu; Luo, Junhang
肿瘤
肿瘤免疫
肾癌
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

The impact of tumor size on the survival of patients with small renal masses: A population-based study

肿瘤大小对小肾脏肿块患者生存率的影响：一项基于人群的研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.4595
Tang, Yiming; Liu, Fei; Mao, Xiaopeng; Li, Pengju; Mumin, Mukhtar A; Li, Jiaying; Hou, Yi; Song, Hongde; Lin, Haishan; Tan, Lei; Gui, Chengpeng; Zhang, Mingxiao; Fu, Liangmin; Chen, Wei; Huang, Yong; Luo, Junhang
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Gene set enrichment analysis and meta-analysis identified 12 key genes regulating and controlling the prognosis of lung adenocarcinoma

基因集富集分析和荟萃分析鉴定出12个调控和控制肺腺癌预后的关键基因。

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2019.10236
He, Wenwu; Fu, Liangmin; Yan, Qunlun; Zhou, Qiuxi; Yuan, Kun; Chen, Linxin; Han, Yongtao
信号转导
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

A five-gene signature to predict the overall survival time of patients with esophageal squamous cell carcinoma

预测食管鳞状细胞癌患者总生存期的五基因特征

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2019.10449
He, Wenwu; Yan, Qunlun; Fu, Liangmin; Han, Yongtao
细胞生物学
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏